Bausch + Lomb Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Brent Saunders
Chief executive officer
US$45.3m
Total compensation
| CEO salary percentage | 3.1% |
| CEO tenure | 2yrs |
| CEO ownership | 0.05% |
| Management average tenure | 2yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | -US$317m |
| Sep 30 2024 | n/a | n/a | -US$368m |
| Jun 30 2024 | n/a | n/a | -US$456m |
| Mar 31 2024 | n/a | n/a | -US$337m |
| Dec 31 2023 | US$45m | US$1m | -US$260m |
Compensation vs Market: Brent's total compensation ($USD45.31M) is above average for companies of similar size in the Canadian market ($USD4.23M).
Compensation vs Earnings: Insufficient data to compare Brent's compensation with company performance.
CEO
Brent Saunders (54 yo)
2yrs
Tenure
US$45,309,051
Compensation
Mr. Brenton L. Saunders, also known as Brent, J.D., is Member of Scientific & Strategic Advisor of Junevity Inc. He serves as Senior Advisor of Fifth Down Cap LLC since 2025. Mr. Saunders is CEO & Chairman...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$45.31m | 0.052% CA$ 4.1m | |
| Executive VP & CFO | 3.2yrs | US$4.76m | 0.011% CA$ 847.8k | |
| Executive VP & Chief Legal Officer | 1.9yrs | US$5.21m | 0.011% CA$ 818.3k | |
| Executive VP of Research & Development and Chief Medical officer | 3.2yrs | US$2.66m | 0.0080% CA$ 619.4k | |
| President of Global Pharmaceuticals & International Consumer | 2.2yrs | US$1.93m | 0.0029% CA$ 224.6k | |
| Executive VP and Chief Supply Chain & Operations Officer | 2.2yrs | no data | no data | |
| Senior VP | no data | no data | 0.0034% CA$ 265.0k | |
| Chief Compliance Officer | 1.6yrs | no data | no data | |
| Chief Communications Officer | 1.8yrs | no data | no data | |
| Chief Corporate Development & Digital Officer | 1.8yrs | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.6yrs | no data | no data | |
| President of Surgical | no data | no data | 0.0044% CA$ 341.9k |
2.0yrs
Average Tenure
54yo
Average Age
Experienced Management: BLCO's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$45.31m | 0.052% CA$ 4.1m | |
| Lead Independent Director | 2yrs | US$396.30k | 0.0036% CA$ 275.9k | |
| Independent Director | 2.9yrs | US$312.46k | 0.0094% CA$ 728.2k | |
| Independent Director | 2.9yrs | US$337.50k | 0.0053% CA$ 411.9k | |
| Independent Director | 2.8yrs | US$312.50k | 0.0074% CA$ 575.8k | |
| Independent Director | 2.9yrs | US$327.45k | 0.0016% CA$ 128.2k | |
| Independent Director | 2.9yrs | US$327.50k | 0.0072% CA$ 558.8k | |
| Independent Director | 1.1yrs | no data | 0.00075% CA$ 58.3k | |
| Independent Director | 2.9yrs | US$324.95k | 0.0098% CA$ 763.1k | |
| Independent Director | 2.8yrs | US$335.00k | 0.0074% CA$ 575.8k |
2.8yrs
Average Tenure
64yo
Average Age
Experienced Board: BLCO's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 03:03 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bausch + Lomb Corporation is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Matt Miksic | Barclays |
| Craig Bijou | BofA Global Research |